Head & Neck Cancer: Clinical Trials

Showing 24 trials
Title Investigatorsort icon
A Phase I Study of Debio1347 in Patients with Advanced Cancers Containing FGFR Alterations
[Protocol 13-131]
Voss, Martin, MD
A Phase IB Study of Urelumab (BMS-663513) plus Cetuximab in Patients with Persistent Head and Neck or Colorectal Cancer
[Protocol 14-121]
Segal, Neil, MD, PhD
Development and Validation of a New Patient-Reported Outcome Instrument on the Impact of Altered Facial Appearance Following Oncologic Head and Neck Resection and Reconstruction
[Protocol 07-098]
Pusic, Andrea, MD, MHS
A Phase II Study of Transoral Surgical Removal of HPV-Positive Locally Advanced Oropharynx Cancer Followed by Risk-Stratified Therapy
Relapsed/Refractory
[Protocol 14-035]
Morris, Luc, MD
A Phase I Study of DLYE5953A in Patients with Advanced or Persistent Solid Tumors
[Protocol 14-089]
Modi, Shanu, MD
A Study of Customized Treatment for Nasopharyngeal Cancer Based on Epstein-Barr Virus DNA
Newly Diagnosed
[Protocol 14-162]
Lee, Nancy, MD
Feasibility Study Using Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Head and Neck Cancer Patients
[Protocol 04-070]
Lee, Nancy, MD
A Phase III Study of Postoperative Radiation Therapy with and without Cetuximab for Locally Advanced Resected Head and Neck Cancer
[Protocol 10-081]
Lee, Nancy, MD
A Phase II Study of Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
[Protocol 11-005]
Lee, Nancy, MD
A Phase II Study of IZN-6N4 to Reduce Mouth Sores in Patients with Head and Neck Cancer Receiving Chemotherapy and Radiation Therapy
[Protocol 12-204]
Lee, Nancy, MD
A Phase II Study of Intensity-Modulated Radiation Therapy for the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer
[Protocol 13-070]
Lee, Nancy, MD
A Phase II/III Study of Surgery Followed by Radiation Therapy plus either Cisplatin, Docetaxel, or Both Drugs for High-Risk Squamous Cell Cancer of the Head and Neck
[Protocol 13-115]
Lee, Nancy, MD
A Phase III Study of Dapsone Gel versus Moisturizer (Placebo) to Treat Cetuximab-Related Rash
[Protocol 13-012]
Lacouture, Mario, MD
A Phase II Study of Regorafenib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
[Protocol 13-244]
Ho, Alan, MD, PhD
A Phase I Study of CB-839 in Patients with Advanced Solid Tumors
[Protocol 14-111]
Harding, James, MD
A Phase II Study of Minimally Invasive Surgery Followed by Radiation and Chemotherapy versus Higher Dose Radiation and Chemotherapy for Patients with HPV-Negative Oropharynx Cancer
Relapsed/Refractory
[Protocol 14-038]
Ganly, Ian, MD, PhD
A Phase I/II Study of BYL719 plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Cancer
[Protocol 14-021]
Fury, Matthew, MD, PhD
A Phase IB Study of INC280 plus Cetuximab in Patients with Recurrent or Metastatic Colorectal or Head and Neck Cancer
[Protocol 14-173]
Fury, Matthew, MD, PhD
A Phase I Study of BYL719 Given with Cetuximab and Radiation Therapy in Patients with Stage III/IVB Head and Neck Cancer
[Protocol 14-116]
Fury, Matthew, MD, PhD
A Pilot Study of Ribavirin to Treat Recurrent or Metastatic HPV-Related Cancers
[Protocol 14-211]
Fury, Matthew, MD, PhD
A Phase I Study of Lurbinectedin plus Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 13-170]
Drilon, Alexander, MD
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 13-198]
Callahan, Margaret, MD, PhD
Surviving Oropharynx Cancer: Long-Term Impact of Human Papillomavirus on Quality of Life
[Protocol 10-111]
Baxi, Shrujal, MD
A Phase II Study of Vismodegib plus Radiation Therapy for Locally Advanced Basal Cell Cancers of the Head and Neck
[Protocol 14-022]
Barker, Christopher, MD